Howard Brick

Howard Brick joined Etiometry in 2021 as Chief Strategy Officer, bringing over 20 years of experience in healthcare technology-related information and analytics companies in a variety of executive, commercial, and corporate development roles.

Before joining Etiometry, Howard consulted to and advised medical technology and digital health companies on strategic partnering, financing, and go-to market strategies. Prior roles included SVP of Business Development for Senscio Systems, Managing Director at Ferghana Partners and Managing Director, COO and then CEO of MedPanel, a market intelligence provider to the life sciences industry and to life sciences-focused investors.

Prior to his career in the healthcare vertical, he worked in mortgage banking analytics and practiced law in Boston. Howard holds a B.A. from Dartmouth College and a J.D. from Columbia University Law School.